{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T20:47:41Z","timestamp":1720126061955},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jclinepi.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jclinepi.2018.05.025","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T08:25:00Z","timestamp":1528100700000},"page":"79-86","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bayesian synthesis using prior information on fracture risk from randomized trials to analyze post-market data"],"prefix":"10.1016","volume":"101","author":[{"given":"Ava","family":"John-Baptiste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taryn","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinwah","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine L.","family":"Lipscombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2018.05.025_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Forbes","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2?3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/djr242","article-title":"Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis","volume":"103","author":"Amir","year":"2011","journal-title":"J Natl Cancer"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ije\/dys213","article-title":"Bayesian regression in SAS software","volume":"42","author":"Sullivan","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm","volume":"25","author":"Hux","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1532-5415.2012.04107.x","article-title":"Systematic review of bone health in older women treated with aromatase inhibitors for early-stage breast cancer","volume":"60","author":"Becker","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib10","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/annonc\/mdp033","article-title":"Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial","volume":"20","author":"Rabaglio","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/EDE.0b013e31827886f7","article-title":"P values and statistical practice","volume":"24","author":"Gelman","year":"2013","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/EDE.0b013e3182785741","article-title":"Living with p values: resurrecting a Bayesian perspective on frequentist statistics","volume":"24","author":"Greenland","year":"2013","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib13","series-title":"R: a language and environment for statistical computing","author":"Team","year":"2016"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib14","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib15","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00198-010-1493-x","article-title":"Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients","volume":"22","author":"Neuner","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the intergroup exemestane study (IES): a randomised controlled study","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10549-011-1754-1","article-title":"Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients","volume":"131","author":"Ligibel","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib18","series-title":"Canadian institute for health information discharge abstract database: a validation study","author":"Juurlink","year":"2006"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women","volume":"14","author":"Powles","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial","volume":"11","author":"Cuzick","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jclinepi.2018.05.025_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435617303517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435617303517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T16:00:27Z","timestamp":1541606427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435617303517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":21,"alternative-id":["S0895435617303517"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2018.05.025","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bayesian synthesis using prior information on fracture risk from randomized trials to analyze post-market data","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2018.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}